FDA approves first factor XIa inhibitor to help prevent stroke
The FDA approved Sunharbo asundexian tablets, the first factor XIa inhibitor to reduce stroke risk in specific high-risk adults.
The FDA approved Sunharbo asundexian tablets, the first factor XIa inhibitor to reduce stroke risk in specific high-risk adults.